Herzig Eye Institute is the first North American Eye Care Practice to Offer LipiFlow® Treatment "The Herzig Eye Institute is thrilled to be the first centre in North America to offer patients TearScience’s LipiFlow® system," states Dr. Sheldon Herzig, co-founder and medical director of the Herzig Eye Institute. "This treatment is a leading edge breakthrough that will improve how we treat patients suffering from chronic dry eye. While there is no cure for chronic dry eye, LipiFlow® opens blocked meibomian glands, allowing the glands to resume the natural lipid secretion needed in the tear film to lubricate and prevent evaporation."